Weipeng Zhan
Papers
4
Total Citations
22
H-Index
4
About
Dr. Weipeng Zhan is a pioneering surgeon-researcher at the forefront of robotic-assisted gastrointestinal and hepatobiliary surgery. His work centers on optimizing the da Vinci robotic system for complex abdominal procedures, with a particular focus on developing the innovative “3+2” mode—utilizing three robotic arms and two assistants—to enhance surgical precision and safety. In a landmark 2020 study (6 citations), Dr. Zhan demonstrated the feasibility of this approach in radical gastrectomy for gastric cancer, showing improved outcomes over conventional methods. He further validated the “3+2” mode’s effectiveness in distal pancreatectomy (5 citations), establishing a new standard for minimally invasive pancreatic surgery. Most notably, Dr. Zhan is a trailblazer in telerobotic surgery, leading a prospective controlled trial (2025, 4 citations) that proved the safety and feasibility of performing cholecystectomy over a 5G network—a breakthrough with profound implications for remote surgical care. His recent exploratory study (2024, 7 citations) on advanced robotic techniques in gastrointestinal surgeries underscores his commitment to pushing the boundaries of what is possible in robotic surgery. With a growing citation impact, Dr. Zhan’s work is shaping the future of minimally invasive and tele-surgical medicine.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4